Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host intestinal epithelial and immune cell surface components represent a broad category of molecular structures, including receptors, adhesion molecules, and transporters, that mediate the interaction between the host and the luminal environment. These components are essential for the maintenance of the intestinal barrier and the regulation of mucosal immunity, serving as the primary interface for nutrient absorption and pathogen recognition [1][2]. In inflammatory conditions such as Crohn's disease and ulcerative colitis, the expression and function of these surface molecules are altered, facilitating the pathological infiltration of leukocytes and the breakdown of epithelial integrity. Modern therapeutic interventions, particularly monoclonal antibodies like vedolizumab, specifically target these surface components (e.g., α4β7 integrin) to modulate immune cell trafficking and restore homeostasis [3]. Understanding the spatial and functional distribution of these molecules is critical for developing site-specific drug delivery systems and targeted biologics that minimize systemic side effects. As a collective entity, these components define the pharmacological landscape of the gastrointestinal tract. [1] Mowat AM, Agace WW. Nat Rev Immunol. 2014;14(10):667-685. [2] Okumura R, Takeda K. Exp Mol Med. 2017;49(5):e338. [3] Feagan BG, et al. N Engl J Med. 2013;369(8):699-710.
Antagonism of integrin-mediated leukocyte adhesion to mucosal addressin cell adhesion molecule-1 (MAdCAM-1); competitive inhibition of pathogen binding to epithelial receptors; modulation of cell surface signaling to reinforce barrier integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal epithelial and immune cell surface components.